Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery
Rameshwar S. Cheke, Vaishali M. Patil, Sandip D. Firke, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 272-272
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1071-1071
Open Access | Times Cited: 94
Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis,in vitrobiological evaluation, andin silicoADMET analysis with molecular modeling simulations
Ashraf S. Hassan, Nesrin M. Morsy, Wael M. Aboulthana, et al.
RSC Advances (2023) Vol. 13, Iss. 14, pp. 9281-9303
Open Access | Times Cited: 49
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 26
Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect
Sunil Kumar, Jong‐Min Oh, P. Prabitha, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Synthesis, optical properties, DNA, β-cyclodextrin interaction, hydrogen isotope sensor and computational study of new enantiopure isoxazolidine derivative (ISoXD)
Afnan Alotayeq, Siwar Ghannay, Ibrahim A. Alhagri, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26341-e26341
Open Access | Times Cited: 8
Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket
Chia‐Ying Huang, A. Metz, Roland Lange, et al.
Acta Crystallographica Section D Structural Biology (2024) Vol. 80, Iss. 2, pp. 123-136
Open Access | Times Cited: 6
Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis, in vitro and multiscale molecular modeling approaches
Siwar Ghannay, Budur Saleh Aldhafeeri, Iqrar Ahmad, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25911-e25911
Open Access | Times Cited: 6
Effects of electron donating and withdrawing substituents on crystal structures, cytotoxicity and in silico DNA interactions of isatinoxime Schiff base ligands
Tolga Göktürk, Ramazan Güp, Talip Zengin, et al.
Research on Chemical Intermediates (2025)
Closed Access
Design, synthesis, in vitro, and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents
Iqra Munir, Zahra Batool, Faizullah Khan, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 948-965
Open Access
Synthesis, cytotoxicity, apoptosis-inducing activity and molecular docking studies of novel isatin–podophyllotoxin hybrids
Nguyễn Hà Thành, Ket Tran Van, Hai Pham‐The, et al.
RSC Advances (2025) Vol. 15, Iss. 4, pp. 2825-2839
Open Access
The Effect of 1,2,4-Triazole-3-thiol Derivatives Bearing Hydrazone Moiety on Cancer Cell Migration and Growth of Melanoma, Breast, and Pancreatic Cancer Spheroids
Aida Šermukšnytė, Kristina Kantminienė, Ilona Jonuškienė, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1026-1026
Open Access | Times Cited: 31
Early pharmacological profiling of isatin derivatives as potent and selective cytotoxic agents
Adrián Puerta, Aday González‐Bakker, Pedro Brandão, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116059-116059
Open Access | Times Cited: 5
Medicinal chemistry of non-peptidomimetic dipeptidyl peptidase IV (DPP IV) inhibitors for treatment of Type-2 diabetes mellitus: Insights on recent development
Jaya P. Ambhore, Purushottam R. Laddha, Anjali Nandedkar, et al.
Journal of Molecular Structure (2023) Vol. 1284, pp. 135249-135249
Closed Access | Times Cited: 11
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights
Tarfah Al‐Warhi, Hadia Almahli, Raed M. Maklad, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3203-3203
Open Access | Times Cited: 11
Transition Metal Complexes as Antimalarial Agents: A Review
Apurba Mandal, Rajesh Kushwaha, Arif Ali Mandal, et al.
ChemMedChem (2023) Vol. 18, Iss. 19
Closed Access | Times Cited: 11
Synthesis of isatin-tagged thiadiazoles as anti-breast cancer leads: In-vitro and in-silico investigations
Jyoti Rasgania, Renu Gavadia, Surendra Nimesh, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136464-136464
Closed Access | Times Cited: 11
Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis
Mohamed A. Abdelrahman, Hadia Almahli, Tarfah Al‐Warhi, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8807-8807
Open Access | Times Cited: 16
Synthesis and biological evaluation of novel isatin-hydrazide conjugates as potential antidiabetic agents
Rima D. Alharthy, Syeda Bakhtawar Zahra, Noor Fatima, et al.
Journal of Molecular Structure (2023) Vol. 1288, pp. 135783-135783
Closed Access | Times Cited: 8
Dual-emission ciprofloxacin-gold nanoclusters enable ratiometric sensing of Cu2+, Al3+, and Hg2+
Sayed M. Saleh, Shahad Altaiyah, Reham Ali
Microchimica Acta (2024) Vol. 191, Iss. 4
Closed Access | Times Cited: 2
Ligand-Based Pharmacophoric Design and Anti-inflammatory Evaluation of Triazole Linked Semisynthetic Labdane Conjugates
Sangeetha Mohan, Lekshmy Krishnan, Nithya Madhusoodanan, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1260-1268
Closed Access | Times Cited: 2
Isatin Conjugates as Antibacterial Agents: A Brief Review
Firoj Hassan, Iqbal Azad, Mohd Asif, et al.
Medicinal Chemistry (2022) Vol. 19, Iss. 5, pp. 413-430
Closed Access | Times Cited: 14
Isatin Bis-Indole and Bis-Imidazothiazole Hybrids: Synthesis and Antimicrobial Activity
Francesca Bonvicini, Alessandra Locatelli, Rita Morigi, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5781-5781
Open Access | Times Cited: 13
Design, synthesis and bio-evaluation of indolin-2-ones as potential antidiabetic agents
Itohowo Gabriel Asuquo, Mehwish Solangi, Khalid Mohammed Khan, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 25-42
Closed Access | Times Cited: 6
Computational, Reactivity, Fukui Function, Molecular Docking, and Spectroscopic Studies of a Novel (E)-1-Benzyl-3-(2-(Pyrindin-2-yl)Hydrazono)Indolin-2-One
Dhakshinamurthy Divya, Venkatesan Srinivasan, A. Prabakaran, et al.
Polycyclic aromatic compounds (2023), pp. 1-21
Closed Access | Times Cited: 6
Design and synthesis of triazole-functionalized isatin hybrids with potent anti-proliferative action against triple-negative breast cancer MDA-MB-231 cell line: a hybrid pharmacophore approach
Jyoti Rasgania, Renu Gavadia, Surendra Nimesh, et al.
Journal of the Iranian Chemical Society (2023) Vol. 21, Iss. 2, pp. 429-443
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top